Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

Background. Pancreatic neuroendocrine tumors (NETs) are rare but are frequently diagnosed at advanced stages and require systemic therapy. Patients and methods. This multicenter, open-label, phase II study evaluated sunitinib in Japanese patients with well-differentiated pancreatic NET. Patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Tetsuhide, Okusaka, Takuji, Nishida, Toshirou, Yamao, Kenji, Igarashi, Hisato, Morizane, Chigusa, Kondo, Shunsuke, Mizuno, Nobumasa, Hara, Kazuo, Sawaki, Akira, Hashigaki, Satoshi, Kimura, Nobuyuki, Murakami, Mami, Ohki, Emiko, Chao, Richard C., Imamura, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Phase II Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771378/
https://www.ncbi.nlm.nih.gov/pubmed/23269537
http://dx.doi.org/10.1007/s10637-012-9910-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771378/
https://www.ncbi.nlm.nih.gov/pubmed/23269537
http://dx.doi.org/10.1007/s10637-012-9910-y

Ejemplares similares